HIV Citation List: December 22 - January 6, 2011

Pubmed citations:

1. Novel isatinyl thiosemicarbazones derivatives as potential molecule to combat HIV-TB co-infection. Banerjee, D., P. Yogeeswari, P. Bhat, A. Thomas, M. Srividya, and D. Sriram. European Journal of Medicinal Chemistry, 2011. 46(1): p. 106-21; PMID[21093117].

[Pubmed]. HIV_1222-010611.

2. Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neurons. Borgmann, K., K.S. Rao, V. Labhasetwar, and A. Ghorpade. AIDS Research and Human Retroviruses, 2010. [Epub ahead of print]; PMID[21175357].

[Pubmed].HIV_1222-010611.

3. HIV Protease-Mediated Activation of Sterically Capped Proteasome Inhibitors and Substrates. Buckley, D.L., T.W. Corson, N. Aberle, and C.M. Crews. Journal of the American Chemistry Society, 2010. [Epub ahead of print]; PMID[21186803].

[Pubmed].HIV_1222-010611.

4. Synthesis and biological activity of novel 5'-arylamino-nucleosides by microwave-assisted one-pot tandem Staudinger/aza-Wittig/reduction. Chen, H., J. Zhao, Y. Li, F. Shen, X. Li, Q. Yin, Z. Qin, X. Yan, Y. Wang, P. Zhang, and J. Zhang. Bioorganic and Medical Chemistry Letters, 2011. 21(1): p. 574-6; PMID[21095125].

[Pubmed].HIV_1222-010611.

5. Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid. Curreli, F., H. Zhang, X. Zhang, I. Pyatkin, Z. Victor, A. Altieri, and A.K. Debnath. Bioorganic and Medicinal Chemistry, 2011. 19(1): p. 77-90; PMID[21168336].

[Pubmed].HIV_1222-010611.

6. Iron chelators of the Di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9. Debebe, Z., T. Ammosova, D. Breuer, D.B. Lovejoy, D.S. Kalinowski, P.K. Karla, K. Kumar, M. Jerebtsova, P. Ray, F. Kashanchi, V.R. Gordeuk, D.R. Richardson, and S. Nekhai. Molecular Pharmacology, 2011. 79(1): p. 185-96; PMID[20956357]

[Pubmed].HIV_1222-010611.

7. Triterpene derivatives that inhibit human immunodeficiency virus type 1 replication. Dorr, C.R., S. Yemets, O. Kolomitsyna, P. Krasutsky, and L.M. Mansky. Bioorganic and Medicinal Chemistry Letters, 2011. 21(1): p. 542-5; PMID[21084190].

[Pubmed].HIV_1222-010611.

8. Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly. Fader, L.D., R. Bethell, P. Bonneau, M. Bos, Y. Bousquet, M.G. Cordingley, R. Coulombe, P. Deroy, A.M. Faucher, A. Gagnon, N. Goudreau, C. Grand-Maitre, I. Guse, O. Hucke, S.H. Kawai, J.E. Lacoste, S. Landry, C.T. Lemke, E. Malenfant, S. Mason, S. Morin, J. O'Meara, B. Simoneau, S. Titolo, and C. Yoakim. Bioorganic and Medicinal Chemistry Letters, 2011. 21(1): p. 398-404; PMID[21087861].

[Pubmed].HIV_1222-010611.

9. Isolation of a New Trypsin Inhibitor from the Faba bean (Vicia faba cv. Giza 843) with Potential Medicinal Applications. Fang, E.F., A.A. Hassanien, J.H. Wong, C.S. Bah, S.S. Soliman, and T.B. Ng. Protein and Peptide Letters, 2011. 18(1): p. 64-72; PMID[20955169].

[Pubmed].HIV_1222-010611.

10. Design and Synthesis of Potent HIV-1 Protease Inhibitors Incorporating Hexahydrofuropyranol-Derived High Affinity P(2) Ligands: Structure-Activity Studies and Biological Evaluation. Ghosh, A.K., B.D. Chapsal, A. Baldridge, M.P. Steffey, D.E. Walters, Y. Koh, M. Amano, and H. Mitsuya. Journal of Medicinal Chemistry, 2010. [Epub ahead of print]; PMID[21194227].

[Pubmed].HIV_1222-010611.

11. Design, Synthesis, and Biological Activity of Novel 5-((Arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thi azolidin-4-ones as HIV-1 Fusion Inhibitors Targeting gp41. Jiang, S., S.R. Tala, H. Lu, N.E. Abo-Dya, I. Avan, K. Gyanda, L. Lu, A.R. Katritzky, and A.K. Debnath. Journal of Medicinal Chemistry, 2010. [Epub ahead of print]; PMID[21190369].

[Pubmed].HIV_1222-010611.

12. Potent Strategy To Inhibit HIV-1 by Binding both gp120 and gp41. Kagiampakis, I., A. Gharibi, M.K. Mankowski, B.A. Snyder, R.G. Ptak, K. Alatas, and P.J. Liwang. Antimicrobial Agents and Chemotherapy, 2011. 55(1): p. 264-75; PMID[20956603]

[Pubmed].HIV_1222-010611.

13. Potential of polymeric nanoparticles in AIDS treatment and prevention. Khalil, N.M., E. Carraro, L.F. Cotica, and R.M. Mainardes. Expert Opinion on Drug Delivery, 2011. 8(1): p. 95-112; PMID[21143001].

[Pubmed].HIV_1222-010611.

14. Design, synthesis and biological evaluation of small molecule inhibitors of CD4-gp120 binding based on virtual screening. Lalonde, J.M., M.A. Elban, J.R. Courter, A. Sugawara, T. Soeta, N. Madani, A.M. Princiotto, Y.D. Kwon, P.D. Kwong, A. Schon, E. Freire, J. Sodroski, and A.B. Smith, 3rd. Bioorganic and Medicinal Chemistry, 2011. 19(1): p. 91-101; PMID[21169023].

[Pubmed].HIV_1222-010611.

15. Lectins: production and practical applications. Lam, S.K. and T.B. Ng. Applied Microbiology and Biotechnology, 2011. 89(1): p. 45-55; PMID[20890754].

[Pubmed].HIV_1222-010611.

16. Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections. Lee, S.B., B. Li, S. Jin, and H. Daniell. Plant Biotechnology J, 2011. 9(1): p. 100-15; PMID[20553419].

[Pubmed].HIV_1222-010611.

17. HIV-1 trans-activator protein dysregulates IFN-gamma signaling and contributes to the suppression of autophagy induction. Li, J.C., K.Y. Au, J.W. Fang, H.C. Yim, K.H. Chow, P.L. Ho, and A.S. Lau. Aids, 2011. 25(1): p. 15-25; PMID[21099673].

[Pubmed].HIV_1222-010611.

18. Schinarisanlactone A, a New Bisnortriterpenoid from Schisandra arisanensis. Lin, Y.C., I.W. Lo, S.Y. Chen, P.H. Lin, C.T. Chien, S.Y. Chang, and Y.C. Shen. Organic Letters, 2010. [Epub ahead of print]; PMID[21175150].

[Pubmed].HIV_1222-010611.

19. Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity. Lusso, P., L. Vangelista, R. Cimbro, M. Secchi, F. Sironi, R. Longhi, M. Faiella, O. Maglio, and V. Pavone. FASEB Journal, 2011; PMID[21199933].

[Pubmed].HIV_1222-010611.

20. Involvement of inhibitory factors in the inefficient entry of HIV-1 into the human CD4 positive HUT78 cell line. Maeda, Y., K. Yusa, Y. Nakano, and S. Harada. Virus Research, 2011. 155(1): p. 368-71; PMID[20969902].

[Pubmed].HIV_1222-010611.

21. A RhoA-Derived Peptide Inhibits Human Immunodeficiency Virus-1 Entry in vitro. Maselko, M., C. Ward, and M. Pastey. Current HIV Research, 2011. [Epub ahead of print]; PMID[21198428].

[Pubmed].HIV_1222-010611.

22. Structural characterization and anti-HIV-1 activities of arginine/glutamate-rich polypeptide Luffin P1 from the seeds of sponge gourd (Luffa cylindrical). Ng, Y.M., Y. Yang, K.H. Sze, X. Zhang, Y.T. Zheng, and P.C. Shaw. Journal of Structural Biology, 2010. [Epub ahead of print]; PMID[21195767].

[Pubmed].HIV_1222-010611.

23. RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production. Ramalingam, D., S. Duclair, S.A. Datta, A. Ellington, A. Rein, and V.R. Prasad. Journal of Virology, 2011. 85(1): p. 305-14; PMID[20980522].

[Pubmed].HIV_1222-010611.

24. Complete inactivation of HIV-1 using photo-labeled non-nucleoside reverse transcriptase inhibitors. Rios, A., J. Quesada, D. Anderson, A. Goldstein, T. Fossum, S. Colby-Germinario, and M.A. Wainberg. Virus Research, 2011. 155(1): p. 189-94; PMID[20937333].

[Pubmed].HIV_1222-010611.

25. Allosteric Suppression of HIV-1 Reverse Transcriptase Structural Dynamics upon Inhibitor Binding. Seckler, J.M., M.D. Barkley, and P.L. Wintrode. Biophysical Journal, 2011. 100(1): p. 144-53; PMID[21190666].

[Pubmed].HIV_1222-010611.

26. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization. Shi, J., J. Zhou, V.B. Shah, C. Aiken, and K. Whitby. Journal of Virology, 2011. 85(1): p. 542-9; PMID[20962083].

[Pubmed].HIV_1222-010611.

27. Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication. Skerlj, R., G. Bridger, E. McEachern, C. Harwig, C. Smith, T. Wilson, D. Veale, H. Yee, J. Crawford, K. Skupinska, R. Wauthy, W. Yang, Y. Zhu, D. Bogucki, M. Di Fluri, J. Langille, D. Huskens, E. De Clercq, and D. Schols. Bioorgznic and Medicinal Chemistry Letters, 2011. 21(1): p. 262-6; PMID[21109432].

[Pubmed].HIV_1222-010611.

28. Pyrrolinone-Based Peptidomimetics. "Let the Enzyme or Receptor be the Judge". Smith, A.B., A.K. Charnley, and R. Hirschmann. Accounts of Chemical Research, 2010. [Epub ahead of print]; PMID[21175156].

[Pubmed].HIV_1222-010611.

29. Targeting cell entry of enveloped viruses as an antiviral strategy. Teissier, E., F. Penin, and E.I. Pecheur. Molecules, 2010. 16(1): p. 221-50; PMID[21193846].

[Pubmed].HIV_1222-010611.

30. Rapid access to new bioconjugates of betulonic acid via click chemistry. Vasilevsky, S.F., A.I. Govdi, I.V. Sorokina, T.G. Tolstikova, D.S. Baev, G.A. Tolstikov, V.I. Mamatuyk, and I.V. Alabugin. Bioorganic and Medicinal Chemistry Letters, 2011. 21(1): p. 62-5; PMID[21159508].

[Pubmed].HIV_1222-010611.

31. Novel Compounds Containing Multiple Guanide Groups That Bind the HIV Coreceptor CXCR4. Wilkinson, R.A., S.H. Pincus, J.B. Shepard, S.K. Walton, E.P. Bergin, M. Labib, and M. Teintze. Antimicrob Agents Chemotherapy, 2011. 55(1): p. 255-63; PMID[20937786].

[Pubmed].HIV_1222-010611.

32. Efficient synthesis and biological evaluation of epiceanothic acid and related compounds. Zhang, P., L. Xu, K. Qian, J. Liu, L. Zhang, K.H. Lee, and H. Sun. Bioorganic and Medicinal Chemistry Letters, 2011. 21(1): p. 338-41; PMID[21123066].

[Pubmed].HIV_1222-010611.

ISI Web of Knowledge citations:

33. Selective Serotonin Reuptake Inhibitor Suppression of HIV Infectivity and Replication. Benton, T., K. Lynch, B. Dube, D.R. Gettes, N.B. Tustin, J.P. Lai, D.S. Metzger, J. Blume, S.D. Douglas, and D.L. Evans. Psychosomatic Medicine, 2010. 72(9): p. 925-932; ISI[000284665400013].

[WOS]. HIV_1222-010611.

34. Arylation of 2-Furyl 4-Fluorophenyl Ketone: An Extension of Heck Chemistry towards Novel Integrase Inhibitors. Franchi, L., M. Rinaldi, G. Vignaroli, A. Innitzer, M. Radi, and M. Botta. Synthesis-Stuttgart, 2010(22): p. 3927-3933; ISI[000284533700020].

[WOS]. HIV_1222-010611.

35. 5-Hydroxychromone, An Alternative Scaffold for Anti-HCV 1,3-Diketo Acid (DKA). Lee, C., K.S. Park, H.R. Park, J.C. Park, B. Lee, D.E. Kim, and Y. Chong. Bulletin of the Korean Chemical Society, 2010. 31(11): p. 3471-3474; ISI[000284794100083].

[WOS]. HIV_1222-010611.

36. Targeting the PI3K/Akt Cell Survival Pathway to Induce Cell Death of HIV-1 Infected Macrophages with Alkylphospholipid Compounds. Lucas, A., Y. Kim, O. Rivera-Pabon, S. Chae, D.H. Kim, and B. Kim. PLoS ONE, 2010. 5(9); ISI[000282312600034].

[WOS]. HIV_1222-010611.

37. Synthesis and Anti-HIV Activity of Novel 4 '-Ethyl-5 '-norcarbocyclic Adenosine Phosphonic Acid Analogues. Yoo, J.C., H. Li, W. Lee, and J.H. Hong, . Bulletin of the Korean Chemical Society, 2010. 31(11): p. 3348-3352; ISI[000284794100053].

[WOS]. HIV_1222-010611.

38. 7,8-Secolignans from Schisandra wilsoniana and Their Anti-HIV-1 Activities. Zhang, X.J., G.Y. Yang, R.R. Wang, J.X. Pu, H.D. Sun, W.L. Xiao, and Y.T. Zheng, . Chemistry & Biodiversity, 2010. 7(11): p. 2692-2701; ISI[000284967200003].

[WOS]. HIV_1222-010611.

39. Synthesis and Anti-HIV Activity of Triterpene 3-O-Galactopyranosides, Analogs of Glycyrrhizic Acid. Baltina, L.A., R.M. Kondratenko, O.A. Plyasunova, S.A. Nepogodiev, and R.A. Field. Chemistry of Natural Compounds, 2010. 46(4): p. 576-582; ISI[000284876100016].

[WOS]. HIV_1222-010611.

40. Synthesis and Antiviral Activity of 18 Alpha-Glycyrrhizic Acid and Its Esters. Baltina, L.A., O.V. Stolyarova, R.M. Kondratenko, O.A. Plyasunova, and A.G. Pokrovskii. Pharmaceutical Chemistry Journal, 2010. 44(6): p. 299-302; ISI[000284459800004].

[WOS]. HIV_1222-010611.

41. Sesquiterpene Coumarins from Ferula gumosa. Iranshahi, M., M. Masullo, A. Asili, A. Hamedzadeh, B. Jahanbin, M. Festa, A. Capasso, and S. Piacente. Journal of Natural Products, 2010. 73(11): p. 1958-1962; ISI[000284559100038].

[WOS]. HIV_1222-010611.

42. Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages. Kennedy, E.M., C. Gavegnano, L. Nguyen, R. Slater, A. Lucas, E. Fromentin, R.F. Schinazi, and B. Kim. Journal of Biological Chemistry, 2010. 285(50): p. 39380-39391; ISI[000284941300065].

[WOS]. HIV_1222-010611.

43. Synthesis of SATE Prodrug of 6 '-Fluoro-6 '-methyl-5 '-noradenosine Nucleoside Phosphonic Acid as a New Class of Anti-HIV Agent. Li, H., J.C. Yoo, Y.C. Baik, W. Lee, and J.H. Hong. Bulletin of the Korean Chemical Society, 2010. 31(9): p. 2514-2518; ISI[000283953600015].

[WOS]. HIV_1222-010611.

44. Microwave-assisted synthesis of a novel class of imidazolylthiazolidin-4-ones and evaluation of its biological activities. Modha, S.G., V.P. Mehta, D. Ermolat'ev, J. Balzarini, K. Van Hecke, L. Van Meervelt, and E. Van der Eycken. Molecular Diversity, 2010. 14(4): p. 767-776; ISI[000284598600016].

[WOS]. HIV_1222-010611.

45. Synthesis and Antiviral Evaluation of 1 '-Branched-5 '-Norcarbocyclic Adenosine Phosphonic Acid Analogues. Oh, C.H., K.H. Yoo, and J.H. Hong. Bulletin of the Korean Chemical Society, 2010. 31(9): p. 2473-2478; ISI[000283953600007].

[WOS]. HIV_1222-010611.

46. Synthesis of Novel 4 '-Cyclopropyl-5 '-norcarbocyclic Adenosine Phosphonic Acid Analogues. Shen, G.H. and J.H. Hong. Nucleosides Nucleotides & Nucleic Acids, 2010. 29(11-12): p. 905-919; ISI[000284889700010].

[WOS]. HIV_1222-010611.

47. Gyrase B Inhibitor Impairs HIV-1 Replication by Targeting Hsp90 and the Capsid Protein. Vozzolo, L., B. Loh, P.J. Gane, M. Tribak, L.H. Zhou, I. Anderson, E. Nyakatura, R.G. Jenner, D. Selwood, and A. Fassati. Journal of Biological Chemistry, 2010. 285(50): p. 39314-39328; ISI[000284941300059].

[WOS]. HIV_1222-010611.